Celanese Corp

For the period ended Aug 11, 2025. Filed Aug 11, 2025.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Aug 11, 2025 · Filed Aug 11, 2025

CE$46.49-2.8%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.2 · Table

Table 2

Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited

Q2 '25 · Q1 '25 · 2024 · Q4 '24 · Q3 '24 · Q2 '24 · Q1 '24
(In $ millions, except percentages)
Operating Profit (Loss) / Operating Margin
Engineered Materials	165	11.4%	96	7.5%	(1,191)	(21.3)%	(1,520)	(119.8)%	102	6.9%	138	9.4%	89	6.5%
Acetyl Chain	154	13.8%	162	14.5%	951	20.0%	216	19.5%	239	20.1%	242	20.1%	254	20.1%
Other Activities(1)	(86)		(90)		(469)		(113)		(93)		(130)		(133)
Total	233	9.2%	168	7.0%	(709)	(6.9)%	(1,417)	(60.1)%	248	9.4%	250	9.4%	210	8.0%
Less: Net Earnings (Loss) Attributable to NCI for Engineered Materials	1		2		(1)		2		2		(4)		(1)
Less: Net Earnings (Loss) Attributable to NCI for Acetyl Chain	2		2		9		1		2		2		4
Operating Profit (Loss) Attributable to Celanese Corporation	230	9.1%	164	6.9%	(717)	(7.0)%	(1,420)	(60.2)%	244	9.2%	252	9.5%	207	7.9%
Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation
Engineered Materials	164	11.4%	94	7.3%	(1,190)	(21.3)%	(1,522)	(119.9)%	100	6.8%	142	9.7%	90	6.5%
Acetyl Chain	152	13.6%	160	14.3%	942	19.8%	215	19.4%	237	19.9%	240	20.0%	250	19.8%
Other Activities(1)	(86)		(90)		(469)		(113)		(93)		(130)		(133)
Total	230	9.1%	164	6.9%	(717)	(7.0)%	(1,420)	(60.2)%	244	9.2%	252	9.5%	207	7.9%
Equity Earnings and Dividend Income, Other Income (Expense) Attributable to Celanese Corporation
Engineered Materials	25		17		178		33		46		49		50
Acetyl Chain	43		3		138		35		34		33		36
Other Activities(1)	3		5		48		4		16		13		15
Total	71		25		364		72		96		95		101
Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation
Engineered Materials	—		—		8		8		—		—		—
Acetyl Chain	—		—		—		—		—		—		—
Other Activities(1)	1		2		(28)		(35)		3		2		2
Total	1		2		(20)		(27)		3		2		2
Certain Items Attributable to Celanese Corporation (Table 8)
Engineered Materials	25		15		1,851		1,625		91		74		61
Acetyl Chain	1		5		22		3		5		4		10
Other Activities(1)	16		23		136		68		18		24		26
Total	42		43		2,009		1,696		114		102		97
Adjusted EBIT / Adjusted EBIT Margin
Engineered Materials	214	14.8%	126	9.8%	847	15.1%	144	11.3%	237	16.0%	265	18.1%	201	14.6%
Acetyl Chain	196	17.6%	168	15.1%	1,102	23.1%	253	22.8%	276	23.2%	277	23.0%	296	23.5%
Other Activities(1)	(66)		(60)		(313)		(76)		(56)		(91)		(90)
Total	344	13.6%	234	9.8%	1,636	15.9%	321	13.6%	457	17.3%	451	17.0%	407	15.6%

(1)Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 2

Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.)

Q2 '25 · Q1 '25 · 2024 · Q4 '24 · Q3 '24 · Q2 '24 · Q1 '24
(In $ millions, except percentages)
Depreciation and Amortization Expense(1)
Engineered Materials	112		109		437		114		111		110		102
Acetyl Chain	64		61		244		63		63		61		57
Other Activities(2)	12		10		47		7		13		10		17
Total	188		180		728		184		187		181		176
Operating EBITDA / Operating EBITDA Margin
Engineered Materials	326	22.6%	235	18.3%	1,284	22.9%	258	20.3%	348	23.5%	375	25.6%	303	22.0%
Acetyl Chain	260	23.3%	229	20.5%	1,346	28.3%	316	28.5%	339	28.5%	338	28.1%	353	28.0%
Other Activities(2)	(54)		(50)		(266)		(69)		(43)		(81)		(73)
Total	532	21.0%	414	17.3%	2,364	23.0%	505	21.4%	644	24.3%	632	23.8%	583	22.3%

(1)Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details.

(2)Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 3

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.